An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

With diabetes rates climbing, an upcoming workshop series at the YMCA will provide valuable information and support to those combating the disease. The six-week series on diabetes self-management will ...

Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large ...

With the rate of diabetes growing worldwide, it can feel like the condition is tough to avoid. A large Japanese study reveals ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

To boost community health – the Montana Red Cross is offering free A1C tests for blood donors.One in ten people in the U.S.